Selected research
Market Structure
Global Dry Eye Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Dry Eye market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Dry Eye is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Dry Eye is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Dry Eye is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Dry Eye is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Dry Eye include Johnson & Johnson, Novartis, United Laboratories, Jianfeng Group, URSAPHARM, Thea pharmaceuticals, Sun Pharmaceutical, SIMILASAN and Santen Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Dry Eye market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Dry Eye and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Dry Eye sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dry Eye market size, projected growth trends, production technologies, key applications, and end-use industries.
Dry Eye Segment by Company
Johnson & Johnson
Novartis
United Laboratories
Jianfeng Group
URSAPHARM
Thea pharmaceuticals
Sun Pharmaceutical
SIMILASAN
Santen Pharma
Bausch & Lomb
Allergan
Alcon
Akorn
Dry Eye Segment by Type
Artificial Tears
Anti-inflammatory Drugs
Others
Dry Eye Segment by Application
Hospital
Retail Pharmacy
Others
Dry Eye Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Eye market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Eye and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Eye.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Dry Eye market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dry Eye manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dry Eye in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Dry Eye in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Artificial Tears
- Anti-inflammatory Drugs
- Others
Applications
- Hospital
- Retail Pharmacy
- Others
Companies covered
- Johnson & Johnson
- Novartis
- United Laboratories
- Jianfeng Group
- URSAPHARM
- Thea pharmaceuticals
- Sun Pharmaceutical
- SIMILASAN
- Santen Pharma
- Bausch & Lomb
- Allergan
- Alcon
- Akorn
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Dry Eye Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Dry Eye Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Dry Eye Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Dry Eye Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Dry Eye Market Dynamics
- 2.1 Dry Eye Industry Trends
- 2.2 Dry Eye Industry Drivers
- 2.3 Dry Eye Industry Opportunities and Challenges
- 2.4 Dry Eye Industry Restraints
3 Dry Eye Market by Manufacturers
- 3.1 Global Dry Eye Revenue by Manufacturers (2021-2026)
- 3.2 Global Dry Eye Sales by Manufacturers (2021-2026)
- 3.3 Global Dry Eye Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Dry Eye Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Dry Eye Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Dry Eye Manufacturers, Product Type & Application
- 3.7 Global Dry Eye Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Dry Eye Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Dry Eye Players Market Share by Revenue in 2025
- 3.8.3 2025 Dry Eye Tier 1, Tier 2, and Tier 3
4 Dry Eye Market by Type
- 4.1 Dry Eye Type Introduction
- 4.1.1 Artificial Tears
- 4.1.2 Anti-inflammatory Drugs
- 4.1.3 Others
- 4.2 Global Dry Eye Sales by Type
- 4.2.1 Global Dry Eye Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Dry Eye Sales by Type (2021-2032)
- 4.2.3 Global Dry Eye Sales Market Share by Type (2021-2032)
- 4.3 Global Dry Eye Revenue by Type
- 4.3.1 Global Dry Eye Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Dry Eye Revenue by Type (2021-2032)
- 4.3.3 Global Dry Eye Revenue Market Share by Type (2021-2032)
5 Dry Eye Market by Application
- 5.1 Dry Eye Application Introduction
- 5.1.1 Hospital
- 5.1.2 Retail Pharmacy
- 5.1.3 Others
- 5.2 Global Dry Eye Sales by Application
- 5.2.1 Global Dry Eye Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Dry Eye Sales by Application (2021-2032)
- 5.2.3 Global Dry Eye Sales Market Share by Application (2021-2032)
- 5.3 Global Dry Eye Revenue by Application
- 5.3.1 Global Dry Eye Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Dry Eye Revenue by Application (2021-2032)
- 5.3.3 Global Dry Eye Revenue Market Share by Application (2021-2032)
6 Global Dry Eye Sales by Region
- 6.1 Global Dry Eye Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Dry Eye Sales by Region (2021-2032)
- 6.2.1 Global Dry Eye Sales by Region (2021-2026)
- 6.2.2 Global Dry Eye Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Dry Eye Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Dry Eye Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Dry Eye Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Dry Eye Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Dry Eye Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Dry Eye Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Dry Eye Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Dry Eye Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Dry Eye Revenue by Region
- 7.1 Global Dry Eye Revenue by Region
- 7.1.1 Global Dry Eye Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Dry Eye Revenue by Region (2021-2026)
- 7.1.3 Global Dry Eye Revenue by Region (2027-2032)
- 7.1.4 Global Dry Eye Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Dry Eye Revenue (2021-2032)
- 7.2.2 North America Dry Eye Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Dry Eye Revenue (2021-2032)
- 7.3.2 Europe Dry Eye Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Dry Eye Revenue (2021-2032)
- 7.4.2 Asia-Pacific Dry Eye Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Dry Eye Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Dry Eye Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Johnson & Johnson
- 8.1.1 Johnson & Johnson Company Information
- 8.1.2 Johnson & Johnson Business Overview
- 8.1.3 Johnson & Johnson Dry Eye Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Johnson & Johnson Dry Eye Product Portfolio
- 8.1.5 Johnson & Johnson Recent Developments
- 8.2 Novartis
- 8.2.1 Novartis Company Information
- 8.2.2 Novartis Business Overview
- 8.2.3 Novartis Dry Eye Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Novartis Dry Eye Product Portfolio
- 8.2.5 Novartis Recent Developments
- 8.3 United Laboratories
- 8.3.1 United Laboratories Company Information
- 8.3.2 United Laboratories Business Overview
- 8.3.3 United Laboratories Dry Eye Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 United Laboratories Dry Eye Product Portfolio
- 8.3.5 United Laboratories Recent Developments
- 8.4 Jianfeng Group
- 8.4.1 Jianfeng Group Company Information
- 8.4.2 Jianfeng Group Business Overview
- 8.4.3 Jianfeng Group Dry Eye Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Jianfeng Group Dry Eye Product Portfolio
- 8.4.5 Jianfeng Group Recent Developments
- 8.5 URSAPHARM
- 8.5.1 URSAPHARM Company Information
- 8.5.2 URSAPHARM Business Overview
- 8.5.3 URSAPHARM Dry Eye Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 URSAPHARM Dry Eye Product Portfolio
- 8.5.5 URSAPHARM Recent Developments
- 8.6 Thea pharmaceuticals
- 8.6.1 Thea pharmaceuticals Company Information
- 8.6.2 Thea pharmaceuticals Business Overview
- 8.6.3 Thea pharmaceuticals Dry Eye Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Thea pharmaceuticals Dry Eye Product Portfolio
- 8.6.5 Thea pharmaceuticals Recent Developments
- 8.7 Sun Pharmaceutical
- 8.7.1 Sun Pharmaceutical Company Information
- 8.7.2 Sun Pharmaceutical Business Overview
- 8.7.3 Sun Pharmaceutical Dry Eye Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Sun Pharmaceutical Dry Eye Product Portfolio
- 8.7.5 Sun Pharmaceutical Recent Developments
- 8.8 SIMILASAN
- 8.8.1 SIMILASAN Company Information
- 8.8.2 SIMILASAN Business Overview
- 8.8.3 SIMILASAN Dry Eye Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 SIMILASAN Dry Eye Product Portfolio
- 8.8.5 SIMILASAN Recent Developments
- 8.9 Santen Pharma
- 8.9.1 Santen Pharma Company Information
- 8.9.2 Santen Pharma Business Overview
- 8.9.3 Santen Pharma Dry Eye Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Santen Pharma Dry Eye Product Portfolio
- 8.9.5 Santen Pharma Recent Developments
- 8.10 Bausch & Lomb
- 8.10.1 Bausch & Lomb Company Information
- 8.10.2 Bausch & Lomb Business Overview
- 8.10.3 Bausch & Lomb Dry Eye Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Bausch & Lomb Dry Eye Product Portfolio
- 8.10.5 Bausch & Lomb Recent Developments
- 8.11 Allergan
- 8.11.1 Allergan Company Information
- 8.11.2 Allergan Business Overview
- 8.11.3 Allergan Dry Eye Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Allergan Dry Eye Product Portfolio
- 8.11.5 Allergan Recent Developments
- 8.12 Alcon
- 8.12.1 Alcon Company Information
- 8.12.2 Alcon Business Overview
- 8.12.3 Alcon Dry Eye Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Alcon Dry Eye Product Portfolio
- 8.12.5 Alcon Recent Developments
- 8.13 Akorn
- 8.13.1 Akorn Company Information
- 8.13.2 Akorn Business Overview
- 8.13.3 Akorn Dry Eye Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Akorn Dry Eye Product Portfolio
- 8.13.5 Akorn Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Dry Eye Value Chain Analysis
- 9.1.1 Dry Eye Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Dry Eye Production Mode & Process
- 9.2 Dry Eye Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Dry Eye Distributors
- 9.2.3 Dry Eye Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst